APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipients

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Excipients Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipients Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipients Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipients Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipients Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 4%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific, have a share over 57 percent. In terms of Production, Cellulose and Derivatives is the largest segment, with a share over 51%. And in terms of Application, the largest application is Solid Preparation Excipients, followed by Semi-Solid Preparation Excipients, Liquid Preparation Excipients, etc.

This report provides an overview of the global Pharmaceutical Excipients market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Excipients and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

Read the full market overview

The report also presents Pharmaceutical Excipients sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Excipients market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Excipients Segment by Company

DuPont (FMC)

JRS Pharma

BASF

Lubrizol

Ashland

Croda International

Roquette

Shin-Etsu

Evonik

Associated British Foods

Hnerkang

Anhui Sunhere Pharmaceutical Excipients

Chase Sun

Pharmaceutical Excipients Segment by Type

Cellulose and Derivatives

Starch and Derivatives

Inorganic Salts

Medicinal Sucrose

Other

Pharmaceutical Excipients Segment by Application

Formulation Stability Excipients

Solid Preparation Excipients

Semi-Solid Preparation Excipients

Liquid Preparation Excipients

Other

Pharmaceutical Excipients Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Excipients status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Excipients market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Excipients significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Excipients competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Excipients market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Excipients industry.

Chapter 3: Detailed analysis of Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Excipients in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Excipients Industry Trends Table 2. Pharmaceutical Excipients Industry Drivers Table 3. Pharmaceutical Excipients Industry Opportunities and Challenges Table 4. Pharmaceutical Excipients Industry Restraints Table 5. Global Pharmaceutical Excipients Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Excipients Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Excipients Sales Volume by Company (K Ton) & (2021-2026) Table 8. Global Pharmaceutical Excipients Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Excipients Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Pharmaceutical Excipients Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Excipients Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Excipients Company, Product Type & Application Table 13. Global Pharmaceutical Excipients Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Cellulose and Derivatives Table 18. Significant Companies of Starch and Derivatives Table 19. Significant Companies of Inorganic Salts Table 20. Significant Companies of Medicinal Sucrose Table 21. Significant Companies of Other Table 22. Global Pharmaceutical Excipients Sales Volume by Type 2021 VS 2025 VS 2032 (K Ton) Table 23. Global Pharmaceutical Excipients Sales Volume by Type (2021-2026) & (K Ton) Table 24. Global Pharmaceutical Excipients Sales Volume by Type (2027-2032) & (K Ton) Table 25. Global Pharmaceutical Excipients Sales Volume Share by Type (2021-2026) Table 26. Global Pharmaceutical Excipients Sales Volume Share by Type (2027-2032) Table 27. Global Pharmaceutical Excipients Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Pharmaceutical Excipients Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Pharmaceutical Excipients Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Pharmaceutical Excipients Sales Value Share by Type (2021-2026) Table 31. Global Pharmaceutical Excipients Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Formulation Stability Excipients Table 33. Significant Companies of Solid Preparation Excipients Table 34. Significant Companies of Semi-Solid Preparation Excipients Table 35. Significant Companies of Liquid Preparation Excipients Table 36. Significant Companies of Other Table 37. Global Pharmaceutical Excipients Sales Volume by Application 2021 VS 2025 VS 2032 (K Ton) Table 38. Global Pharmaceutical Excipients Sales Volume by Application (2021-2026) & (K Ton) Table 39. Global Pharmaceutical Excipients Sales Volume by Application (2027-2032) & (K Ton) Table 40. Global Pharmaceutical Excipients Sales Volume Share by Application (2021-2026) Table 41. Global Pharmaceutical Excipients Sales Volume Share by Application (2027-2032) Table 42. Global Pharmaceutical Excipients Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Pharmaceutical Excipients Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Pharmaceutical Excipients Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Pharmaceutical Excipients Sales Value Share by Application (2021-2026) Table 46. Global Pharmaceutical Excipients Sales Value Share by Application (2027-2032) Table 47. Global Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032 (K Ton) Table 48. Global Pharmaceutical Excipients Sales by Region (2021-2026) & (K Ton) Table 49. Global Pharmaceutical Excipients Sales Market Share by Region (2021-2026) Table 50. Global Pharmaceutical Excipients Sales by Region (2027-2032) & (K Ton) Table 51. Global Pharmaceutical Excipients Sales Market Share by Region (2027-2032) Table 52. Global Pharmaceutical Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Pharmaceutical Excipients Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Pharmaceutical Excipients Sales Value Share by Region (2021-2026) Table 55. Global Pharmaceutical Excipients Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Pharmaceutical Excipients Sales Value Share by Region (2027-2032) Table 57. Global Pharmaceutical Excipients Market Average Price (US$/Ton) by Region (2021-2026) Table 58. Global Pharmaceutical Excipients Market Average Price (US$/Ton) by Region (2027-2032) Table 59. Global Pharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032 (K Ton) Table 60. Global Pharmaceutical Excipients Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pharmaceutical Excipients Sales by Country (2021-2026) & (K Ton) Table 62. Global Pharmaceutical Excipients Sales Market Share by Country (2021-2026) Table 63. Global Pharmaceutical Excipients Sales by Country (2027-2032) & (K Ton) Table 64. Global Pharmaceutical Excipients Sales Market Share by Country (2027-2032) Table 65. Global Pharmaceutical Excipients Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Pharmaceutical Excipients Sales Value Market Share by Country (2021-2026) Table 67. Global Pharmaceutical Excipients Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Pharmaceutical Excipients Sales Value Market Share by Country (2027-2032) Table 69. DuPont (FMC) Company Information Table 70. DuPont (FMC) Business Overview Table 71. DuPont (FMC) Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. DuPont (FMC) Pharmaceutical Excipients Product Portfolio Table 73. DuPont (FMC) Recent Development Table 74. JRS Pharma Company Information Table 75. JRS Pharma Business Overview Table 76. JRS Pharma Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. JRS Pharma Pharmaceutical Excipients Product Portfolio Table 78. JRS Pharma Recent Development Table 79. BASF Company Information Table 80. BASF Business Overview Table 81. BASF Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. BASF Pharmaceutical Excipients Product Portfolio Table 83. BASF Recent Development Table 84. Lubrizol Company Information Table 85. Lubrizol Business Overview Table 86. Lubrizol Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Lubrizol Pharmaceutical Excipients Product Portfolio Table 88. Lubrizol Recent Development Table 89. Ashland Company Information Table 90. Ashland Business Overview Table 91. Ashland Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Ashland Pharmaceutical Excipients Product Portfolio Table 93. Ashland Recent Development Table 94. Croda International Company Information Table 95. Croda International Business Overview Table 96. Croda International Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Croda International Pharmaceutical Excipients Product Portfolio Table 98. Croda International Recent Development Table 99. Roquette Company Information Table 100. Roquette Business Overview Table 101. Roquette Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. Roquette Pharmaceutical Excipients Product Portfolio Table 103. Roquette Recent Development Table 104. Shin-Etsu Company Information Table 105. Shin-Etsu Business Overview Table 106. Shin-Etsu Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Shin-Etsu Pharmaceutical Excipients Product Portfolio Table 108. Shin-Etsu Recent Development Table 109. Evonik Company Information Table 110. Evonik Business Overview Table 111. Evonik Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. Evonik Pharmaceutical Excipients Product Portfolio Table 113. Evonik Recent Development Table 114. Associated British Foods Company Information Table 115. Associated British Foods Business Overview Table 116. Associated British Foods Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. Associated British Foods Pharmaceutical Excipients Product Portfolio Table 118. Associated British Foods Recent Development Table 119. Hnerkang Company Information Table 120. Hnerkang Business Overview Table 121. Hnerkang Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 122. Hnerkang Pharmaceutical Excipients Product Portfolio Table 123. Hnerkang Recent Development Table 124. Anhui Sunhere Pharmaceutical Excipients Company Information Table 125. Anhui Sunhere Pharmaceutical Excipients Business Overview Table 126. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 127. Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Product Portfolio Table 128. Anhui Sunhere Pharmaceutical Excipients Recent Development Table 129. Chase Sun Company Information Table 130. Chase Sun Business Overview Table 131. Chase Sun Pharmaceutical Excipients Sales (K Ton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 132. Chase Sun Pharmaceutical Excipients Product Portfolio Table 133. Chase Sun Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Pharmaceutical Excipients Distributors List Table 137. Pharmaceutical Excipients Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Pharmaceutical Excipients Product Image Figure 2. Global Pharmaceutical Excipients Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Excipients Sales (2021-2032) & (K Ton) Figure 5. Global Pharmaceutical Excipients Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Pharmaceutical Excipients Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Cellulose and Derivatives Image Figure 10. Starch and Derivatives Image Figure 11. Inorganic Salts Image Figure 12. Medicinal Sucrose Image Figure 13. Other Image Figure 14. Global Pharmaceutical Excipients Sales Volume by Type (2021 VS 2025 VS 2032) & (K Ton) Figure 15. Global Pharmaceutical Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Excipients Sales Volume Share by Type (2021-2032) Figure 17. Global Pharmaceutical Excipients Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Excipients Sales Value Share by Type (2021-2032) Figure 20. Formulation Stability Excipients Image Figure 21. Solid Preparation Excipients Image Figure 22. Semi-Solid Preparation Excipients Image Figure 23. Liquid Preparation Excipients Image Figure 24. Other Image Figure 25. Global Pharmaceutical Excipients Sales Volume by Application (2021 VS 2025 VS 2032) & (K Ton) Figure 26. Global Pharmaceutical Excipients Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Pharmaceutical Excipients Sales Volume Share by Application (2021-2032) Figure 28. Global Pharmaceutical Excipients Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pharmaceutical Excipients Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Pharmaceutical Excipients Sales Value Share by Application (2021-2032) Figure 31. Global Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032 (K Ton) Figure 32. Global Pharmaceutical Excipients Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Pharmaceutical Excipients Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Pharmaceutical Excipients Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 36. North America Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 42. South America Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Pharmaceutical Excipients Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Pharmaceutical Excipients Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Pharmaceutical Excipients Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Pharmaceutical Excipients Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Pharmaceutical Excipients Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Cellulose and Derivatives
  • Starch and Derivatives
  • Inorganic Salts
  • Medicinal Sucrose
  • Other
Applications
  • Formulation Stability Excipients
  • Solid Preparation Excipients
  • Semi-Solid Preparation Excipients
  • Liquid Preparation Excipients
  • Other
Companies covered
  • DuPont (FMC)
  • JRS Pharma
  • BASF
  • Lubrizol
  • Ashland
  • Croda International
  • Roquette
  • Shin-Etsu
  • Evonik
  • Associated British Foods
  • Hnerkang
  • Anhui Sunhere Pharmaceutical Excipients
  • Chase Sun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Excipients Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Excipients Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Excipients Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Excipients Market Dynamics
  1. 2.1 Pharmaceutical Excipients Industry Trends
  2. 2.2 Pharmaceutical Excipients Industry Drivers
  3. 2.3 Pharmaceutical Excipients Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Excipients Industry Restraints
3 Pharmaceutical Excipients Market by Company
  1. 3.1 Global Pharmaceutical Excipients Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Excipients Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Excipients Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Excipients Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Excipients Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Excipients Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Excipients Company Product Type and Application
  8. 3.8 Global Pharmaceutical Excipients Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Excipients Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Excipients Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Excipients Market by Type
  1. 4.1 Pharmaceutical Excipients Type Introduction
  2. 4.1.1 Cellulose and Derivatives
  3. 4.1.2 Starch and Derivatives
  4. 4.1.3 Inorganic Salts
  5. 4.1.4 Medicinal Sucrose
  6. 4.1.5 Other
  7. 4.2 Global Pharmaceutical Excipients Sales Volume by Type
  8. 4.2.1 Global Pharmaceutical Excipients Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Pharmaceutical Excipients Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Pharmaceutical Excipients Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Pharmaceutical Excipients Sales Value by Type
  12. 4.3.1 Global Pharmaceutical Excipients Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Pharmaceutical Excipients Sales Value by Type (2021-2032)
  14. 4.3.3 Global Pharmaceutical Excipients Sales Value Share by Type (2021-2032)
5 Pharmaceutical Excipients Market by Application
  1. 5.1 Pharmaceutical Excipients Application Introduction
  2. 5.1.1 Formulation Stability Excipients
  3. 5.1.2 Solid Preparation Excipients
  4. 5.1.3 Semi-Solid Preparation Excipients
  5. 5.1.4 Liquid Preparation Excipients
  6. 5.1.5 Other
  7. 5.2 Global Pharmaceutical Excipients Sales Volume by Application
  8. 5.2.1 Global Pharmaceutical Excipients Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Pharmaceutical Excipients Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Pharmaceutical Excipients Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Pharmaceutical Excipients Sales Value by Application
  12. 5.3.1 Global Pharmaceutical Excipients Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Pharmaceutical Excipients Sales Value by Application (2021-2032)
  14. 5.3.3 Global Pharmaceutical Excipients Sales Value Share by Application (2021-2032)
6 Pharmaceutical Excipients Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Excipients Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Excipients Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Excipients Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Excipients Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Excipients Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Excipients Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Excipients Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Excipients Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Excipients Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Excipients Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Excipients Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Excipients Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Excipients Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Excipients Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Excipients Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Excipients Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Excipients Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Excipients Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Excipients Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Excipients Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Excipients Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Excipients Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Excipients Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Excipients Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Excipients Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Excipients Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Excipients Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DuPont (FMC)
  2. 8.1.1 DuPont (FMC) Company Information
  3. 8.1.2 DuPont (FMC) Business Overview
  4. 8.1.3 DuPont (FMC) Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 DuPont (FMC) Pharmaceutical Excipients Product Portfolio
  6. 8.1.5 DuPont (FMC) Recent Developments
  7. 8.2 JRS Pharma
  8. 8.2.1 JRS Pharma Company Information
  9. 8.2.2 JRS Pharma Business Overview
  10. 8.2.3 JRS Pharma Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 JRS Pharma Pharmaceutical Excipients Product Portfolio
  12. 8.2.5 JRS Pharma Recent Developments
  13. 8.3 BASF
  14. 8.3.1 BASF Company Information
  15. 8.3.2 BASF Business Overview
  16. 8.3.3 BASF Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BASF Pharmaceutical Excipients Product Portfolio
  18. 8.3.5 BASF Recent Developments
  19. 8.4 Lubrizol
  20. 8.4.1 Lubrizol Company Information
  21. 8.4.2 Lubrizol Business Overview
  22. 8.4.3 Lubrizol Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Lubrizol Pharmaceutical Excipients Product Portfolio
  24. 8.4.5 Lubrizol Recent Developments
  25. 8.5 Ashland
  26. 8.5.1 Ashland Company Information
  27. 8.5.2 Ashland Business Overview
  28. 8.5.3 Ashland Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ashland Pharmaceutical Excipients Product Portfolio
  30. 8.5.5 Ashland Recent Developments
  31. 8.6 Croda International
  32. 8.6.1 Croda International Company Information
  33. 8.6.2 Croda International Business Overview
  34. 8.6.3 Croda International Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Croda International Pharmaceutical Excipients Product Portfolio
  36. 8.6.5 Croda International Recent Developments
  37. 8.7 Roquette
  38. 8.7.1 Roquette Company Information
  39. 8.7.2 Roquette Business Overview
  40. 8.7.3 Roquette Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Roquette Pharmaceutical Excipients Product Portfolio
  42. 8.7.5 Roquette Recent Developments
  43. 8.8 Shin-Etsu
  44. 8.8.1 Shin-Etsu Company Information
  45. 8.8.2 Shin-Etsu Business Overview
  46. 8.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shin-Etsu Pharmaceutical Excipients Product Portfolio
  48. 8.8.5 Shin-Etsu Recent Developments
  49. 8.9 Evonik
  50. 8.9.1 Evonik Company Information
  51. 8.9.2 Evonik Business Overview
  52. 8.9.3 Evonik Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Evonik Pharmaceutical Excipients Product Portfolio
  54. 8.9.5 Evonik Recent Developments
  55. 8.10 Associated British Foods
  56. 8.10.1 Associated British Foods Company Information
  57. 8.10.2 Associated British Foods Business Overview
  58. 8.10.3 Associated British Foods Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Associated British Foods Pharmaceutical Excipients Product Portfolio
  60. 8.10.5 Associated British Foods Recent Developments
  61. 8.11 Hnerkang
  62. 8.11.1 Hnerkang Company Information
  63. 8.11.2 Hnerkang Business Overview
  64. 8.11.3 Hnerkang Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hnerkang Pharmaceutical Excipients Product Portfolio
  66. 8.11.5 Hnerkang Recent Developments
  67. 8.12 Anhui Sunhere Pharmaceutical Excipients
  68. 8.12.1 Anhui Sunhere Pharmaceutical Excipients Company Information
  69. 8.12.2 Anhui Sunhere Pharmaceutical Excipients Business Overview
  70. 8.12.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients Product Portfolio
  72. 8.12.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments
  73. 8.13 Chase Sun
  74. 8.13.1 Chase Sun Company Information
  75. 8.13.2 Chase Sun Business Overview
  76. 8.13.3 Chase Sun Pharmaceutical Excipients Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Chase Sun Pharmaceutical Excipients Product Portfolio
  78. 8.13.5 Chase Sun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Excipients Value Chain Analysis
  2. 9.1.1 Pharmaceutical Excipients Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Excipients Sales Mode & Process
  6. 9.2 Pharmaceutical Excipients Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Excipients Distributors
  9. 9.2.3 Pharmaceutical Excipients Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst